ID   BP50
AC   CVCL_C0UF
SY   Bascom Palmer 50
DR   Wikidata; Q112929343
RX   PubMed=34043754;
CC   Doubling time: 52.3 hours (PubMed=34043754).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; c.264+2T>C; ClinVar=VCV003237116; Zygosity=Unspecified; Note=Splice donor mutation, germline mutation (PubMed=34043754).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Eye, ocular adnexa; UBERON=UBERON_0035639.
ST   Source(s): PubMed=34043754
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D21S11: 28,31.2
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 7,16
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 18,20
DI   NCIt; C43340; Eye sebaceous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
RX   PubMed=34043754; DOI=10.1167/tvst.10.6.34; PMCID=PMC8161695;
RA   Rong A.J., Gallo R.A., Zhang M.G., Doddapaneni R., Griswold A.J.,
RA   Lee J.Y., Kurtenbach S., Dubovy S.R., Tse D.T., Pelaez D.;
RT   "Establishment and characterization of a novel human ocular adnexal
RT   sebaceous carcinoma cell line.";
RL   Transl. Vis. Sci. Technol. 10:34.1-34.8(2021).
//